RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases
2024 Kawano-Dourado, Leticia; Kulkarni, Tejaswini; Ryerson, Christopher J; Rivera-Ortega, Pilar; Baldi, Bruno Guedes; Chaudhuri, Nazia; Funke-Chambour, Manuela; Hoffmann-Vold, Anna-Maria; Johannson, Kerri A; Khor, Yet Hong; Montesi, Sydney B; Piccari, Lucilla; Prosch, Helmut; Molina-Molina, María; Sellares Torres, Jacobo; Bauer-Ventura, Iazsmin; Rajan, Sujeet; Jacob, Joseph; Richards, Duncan; Spencer, Lisa G; Wendelberger, Barbara; Jensen, Tom; Quintana, Melanie; Kreuter, Michael; Gordon, Anthony C; Martinez, Fernando J; Kaminski, Naftali; Cornelius, Victoria; Lewis, Roger; Adams, Wendy; Jenkins, Gisli; Richeldi, Luca
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis
2024 Simonetti, Jacopo; Ficili, Marco; Sgalla, Giacomo; Richeldi, Luca
Reply to: Cottin et al., Johannson et al., Scholand and Wells, and Crowley et al
2023 Raghu, Ganesh; Richeldi, Luca; Thomson, Carey C; Remy-Jardin, Martine; Wilson, Kevin C
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis
2023 Podolanczuk, Anna J; Richeldi, Luca; Martinez, Fernando J
Treatable traits in interstitial lung diseases: a call to action
2023 Amati, Francesco; Spagnolo, Paolo; Oldham, Justin M; Ryerson, Christopher J; Stainer, Anna; Gramegna, Andrea; Mantero, Marco; Lacedonia, Donato; Sverzellati, Nicola; Richeldi, Luca; Blasi, Francesco; Aliberti, Stefano
Walking the path of treatable traits in interstitial lung diseases
2023 Amati, Francesco; Spagnolo, Paolo; Ryerson, Christopher J.; Oldham, Justin M.; Gramegna, Andrea; Stainer, Anna; Mantero, Marco; Sverzellati, Nicola; Lacedonia, Donato; Richeldi, Luca; Blasi, Francesco; Aliberti, Stefano
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia
2023 Sgalla, Giacomo; Leone, Paolo Maria; Gualano, Gina; Simonetti, Jacopo; Comes, Alessia; Verdirosi, Diana; Di Gennaro, Francesco; Larici, Anna Rita; Ianniello, Stefania; Cicchetti, Giuseppe; Fusco, Nicoletta; Pani, Marcello; Palmieri, Fabrizio; Richeldi, Luca
Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?
2022 Raghu, Ganesh; Richeldi, Luca; Thomson, Carey C; Remy-Jardin, Martine; Wilson, Kevin C
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease
2022 Wong, Alyson W; Khor, Yet H; Donohoe, Kathryn; Comes, Alessia; Marcoux, Veronica; Fisher, Jolene H; Johannson, Kerri A; Assayag, Deborah; Morisset, Julie; Shapera, Shane; Khalil, Nasreen; Fell, Charlene D; Manganas, Helene; Cox, Gerard; To, Teresa; Gershon, Andrea S; Hambly, Nathan; Halayko, Andrew J; Sadatsafavi, Mohsen; Wilcox, Pearce G; Kolb, Martin; Richeldi, Luca; Ryerson, Christopher J
Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary Fibrosis. Reply
2022 Richeldi, Luca; Stowasser, Susanne; Maher, Toby M
Data di pubblicazione | Titolo | Autore(i) | File |
---|---|---|---|
1-gen-2024 | Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases | Kawano-Dourado, Leticia; Kulkarni, Tejaswini; Ryerson, Christopher J; Rivera-Ortega, Pilar; Baldi, Bruno Guedes; Chaudhuri, Nazia; Funke-Chambour, Manuela; Hoffmann-Vold, Anna-Maria; Johannson, Kerri A; Khor, Yet Hong; Montesi, Sydney B; Piccari, Lucilla; Prosch, Helmut; Molina-Molina, María; Sellares Torres, Jacobo; Bauer-Ventura, Iazsmin; Rajan, Sujeet; Jacob, Joseph; Richards, Duncan; Spencer, Lisa G; Wendelberger, Barbara; Jensen, Tom; Quintana, Melanie; Kreuter, Michael; Gordon, Anthony C; Martinez, Fernando J; Kaminski, Naftali; Cornelius, Victoria; Lewis, Roger; Adams, Wendy; Jenkins, Gisli; Richeldi, Luca | |
1-gen-2024 | Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis | Simonetti, Jacopo; Ficili, Marco; Sgalla, Giacomo; Richeldi, Luca | |
1-gen-2023 | Reply to: Cottin et al., Johannson et al., Scholand and Wells, and Crowley et al | Raghu, Ganesh; Richeldi, Luca; Thomson, Carey C; Remy-Jardin, Martine; Wilson, Kevin C | |
1-gen-2023 | The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis | Podolanczuk, Anna J; Richeldi, Luca; Martinez, Fernando J | |
1-gen-2023 | Treatable traits in interstitial lung diseases: a call to action | Amati, Francesco; Spagnolo, Paolo; Oldham, Justin M; Ryerson, Christopher J; Stainer, Anna; Gramegna, Andrea; Mantero, Marco; Lacedonia, Donato; Sverzellati, Nicola; Richeldi, Luca; Blasi, Francesco; Aliberti, Stefano | |
1-gen-2023 | Walking the path of treatable traits in interstitial lung diseases | Amati, Francesco; Spagnolo, Paolo; Ryerson, Christopher J.; Oldham, Justin M.; Gramegna, Andrea; Stainer, Anna; Mantero, Marco; Sverzellati, Nicola; Lacedonia, Donato; Richeldi, Luca; Blasi, Francesco; Aliberti, Stefano | |
1-gen-2023 | A randomized trial of pamrevlumab in patients with COVID-19 pneumonia | Sgalla, Giacomo; Leone, Paolo Maria; Gualano, Gina; Simonetti, Jacopo; Comes, Alessia; Verdirosi, Diana; Di Gennaro, Francesco; Larici, Anna Rita; Ianniello, Stefania; Cicchetti, Giuseppe; Fusco, Nicoletta; Pani, Marcello; Palmieri, Fabrizio; Richeldi, Luca | |
1-gen-2022 | Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required? | Raghu, Ganesh; Richeldi, Luca; Thomson, Carey C; Remy-Jardin, Martine; Wilson, Kevin C | |
1-gen-2022 | Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease | Wong, Alyson W; Khor, Yet H; Donohoe, Kathryn; Comes, Alessia; Marcoux, Veronica; Fisher, Jolene H; Johannson, Kerri A; Assayag, Deborah; Morisset, Julie; Shapera, Shane; Khalil, Nasreen; Fell, Charlene D; Manganas, Helene; Cox, Gerard; To, Teresa; Gershon, Andrea S; Hambly, Nathan; Halayko, Andrew J; Sadatsafavi, Mohsen; Wilcox, Pearce G; Kolb, Martin; Richeldi, Luca; Ryerson, Christopher J | |
1-gen-2022 | Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary Fibrosis. Reply | Richeldi, Luca; Stowasser, Susanne; Maher, Toby M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
collection
- Editoriale in rivista 47
Data di pubblicazione
- 2024 2
- 2023 5
- 2022 11
- 2021 10
- 2020 11
- 2019 11
- 2018 1
Settore disciplinare
- Settore MED/10 - MALATTIE DELL'AP... 43
- Settore MED/09 - MEDICINA INTERNA 8
Editore
- American Thoracic Society 8
- NLM (Medline) 4
- Blackwell Publishing 3
- TAYLOR & FRANCIS LTD 3
- Elsevier B.V. 2
- W.B. Saunders 2
- Adis 1
- AMER THORACIC SOC 1
- American Association for Respirat... 1
- BMC 1
Accesso al fulltext
- no fulltext 38
- open 13
Keyword
- Humans 20
- Idiopathic Pulmonary Fibrosis 12
- Interstitial 7
- Lung Diseases 7
- COVID-19 6
- Idiopathic pulmonary fibrosis 6
- Lung 4
- pulmonary fibrosis 4
- SARS-CoV-2 4
- Biomarkers 3